Therapeutic Plasma Exchange for Vaccine-Injured and Long COVID Patients with Dr. Phillip Milgram, MD
At AgeReversalMD in La Jolla, California, Therapeutic Plasma Exchange (TPE) is offered as a cornerstone of advanced regenerative medicine for patients suffering from vaccine injury, Long COVID, autoimmune disease, and chronic inflammatory conditions. Under the direction of Dr. Phillip Milgram, MD—a physician with over 47 years of clinical experience and a background in advanced intervention and preventive medicine—this therapy is designed to remove the circulating substances believed to drive chronic post-viral and post-vaccine symptoms, while supporting whole-body cellular recovery.
For patients who have been searching for meaningful treatment, plasma exchange represents a scientifically grounded, physician-supervised path to recovery—available in the United States, without the need to travel overseas.
A Growing Call for Plasma-Based Treatment of Vaccine Injury
On April 23, 2026, leading voices in health freedom and decentralized medicine issued a public call for major U.S. investment in plasma-based blood purification therapy to help vaccine-injured and Long COVID patients. In a statement shared from Houston, patient advocate Kenny Carmody, alongside Dr. Mary Talley Bowden, pointed to the Double Filtration Plasmapheresis (DFPP) protocol developed in Japan as a potentially groundbreaking option.
“The United States and all around the world need to invest in DFPP to help the vaccine injured and long COVID patients,” Carmody wrote. He credited researcher Kevin McCairn, PhD, for mastering and adapting the technology, along with Dr. Bowden and advocate Charles Rixey for their ongoing efforts to support those affected.
Dr. Bowden, a Houston-based otolaryngologist who treats many vaccine-injured patients in her practice, has described plasma exchange as one of the most promising treatments currently under evaluation for injuries from COVID-19 mRNA shots. Early patient results, she said, have been “amazing,” providing renewed hope to those suffering long-term effects.
“Thank you Miss Dr. Bowden, Dr. McCairn, Charles Rixey for caring for the injured and risking everything to help them,” Carmody added. “We just need a bit more resources than the currently funding. We have two amazing Kevin’s on our side. We are seeing amazing results already from many patients. It gives hope to the people.”
The call has drawn attention from a range of independent researchers and clinicians including Kevin McKernan, Lyndsey RN, Bret Weinstein, Chris Martenson, and The Ethical Skeptic, among others who have platformed patient stories and called for more study. Advocates stress that plasma-based therapy represents a science-based, non-pharmaceutical approach offering real hope amid ongoing challenges faced by vaccine-injured individuals.
What Is Therapeutic Plasma Exchange?
Therapeutic Plasma Exchange, also known as plasmapheresis, is a medical procedure that physically removes harmful substances from the bloodstream. Blood is drawn from the patient, separated into its components using a centrifuge, and the plasma—the liquid portion containing circulating proteins, antibodies, cytokines, and toxins—is removed. Clean replacement fluid, typically albumin, is returned to the patient along with the red and white blood cells.
Plasma exchange has been used in clinical medicine for decades and is an established treatment for:
- Autoimmune neurological conditions such as myasthenia gravis and Guillain-Barré syndrome
- Autoimmune encephalitis and antibody-mediated brain inflammation
- Thrombotic thrombocytopenic purpura and other hematologic disorders
- Rejection management in organ transplantation
- Severe lipid disorders and metabolic conditions
Today, that same proven technology is being applied to a new population: patients suffering from post-vaccine syndromes and Long COVID.
Why Plasma Exchange for Vaccine Injury and Long COVID?
A growing body of clinical observation and research suggests that many patients suffering from post-vaccine syndromes and Long COVID share common underlying biological features that circulate in the blood, including:
- Persistent circulating spike protein
- Elevated autoantibodies against neurotransmitter receptors, adrenergic receptors, and acetylcholine receptors
- Amyloid microdeposits and fibrin microclots that impair circulation
- Chronic inflammation driven by elevated cytokines such as IL-6 and IL-1β
- Oxidized lipids and lipoprotein abnormalities
- Environmental toxins bound to plasma proteins
Because these pathogenic substances are circulating in the bloodstream, physically removing them through plasma exchange represents a logical and mechanistically grounded therapeutic approach. Patients describe the effect as a reset: the inflammatory fuel is removed, giving the immune system and nervous system an opportunity to recalibrate.
Research published in Molecular Psychiatry documented that Long COVID patients treated with plasma exchange showed significant reductions in neurotransmitter autoantibodies, inflammatory markers, fibrinogen, and lipid abnormalities, along with clinical improvement in fatigue and cognitive symptoms.
Plasma Exchange in the United States vs. the Japanese DFPP Protocol
Vaccine-injured patients researching treatment options have likely encountered the Double Filtration Plasmapheresis protocol developed in Japan and championed by Dr. Bowden, Kevin McCairn PhD, and patient advocates. The Edogawa Hospital protocol in Tokyo has produced encouraging early patient reports. It uses specialized filtration to remove abnormal amyloid proteins and micro-deposits believed to contribute to patient symptoms, and incorporates interventional stem cell growth factors derived from the pulp of baby teeth to support tissue repair and recovery.
However, for most patients the Japanese protocol is not practical. Dr. Bowden has noted that the treatment is currently available in Japan at a cost of approximately $20,000 to $25,000 per patient including travel, and it requires:
- International travel to Tokyo, often while severely debilitated
- Two to four weeks on-site for the full protocol
- Post-treatment follow-up thousands of miles from home
The goal of Dr. Bowden and the McCairn research team is to bring plasma-based therapy to the United States under approved clinical trials, which would involve securing Institutional Review Board (IRB) approvals and demonstrating safety and efficacy to regulatory bodies such as the FDA. That effort is underway, but trial enrollment and approval timelines mean most patients cannot wait.
Therapeutic Plasma Exchange at AgeReversalMD offers patients a U.S.-based, physician-supervised path to plasma-based treatment today. While TPE and DFPP use different filtration methods, both work on the same underlying principle: removing pathogenic substances from the blood to reduce the inflammatory and autoimmune burden driving symptoms.
What distinguishes Dr. Milgram’s approach is the integration of plasma exchange with other regenerative therapies. TPE alone addresses circulating pathogens. TPE combined with IV NAD+ therapy, peptide protocols, and hormone optimization addresses the cellular recovery and mitochondrial repair needed to rebuild after years of chronic inflammation. This integrated approach is specifically designed for vaccine-injured and Long COVID patients who need both detoxification and regeneration.
Clinical Applications of TPE at AgeReversalMD
Dr. Phillip Milgram offers Therapeutic Plasma Exchange as part of a comprehensive treatment plan for a range of conditions.
Post-Vaccine Syndrome
Patients reporting chronic symptoms following COVID-19 mRNA vaccination may benefit from TPE as a means of removing circulating spike proteins, autoantibodies, inflammatory cytokines, and immune complexes believed to contribute to ongoing symptoms. The procedure provides a physical reduction in circulating pathogenic load that supplements and amplifies other recovery protocols.
Long COVID
Long COVID patients with elevated inflammatory markers, persistent fatigue, brain fog, post-exertional malaise, or autonomic dysfunction may experience meaningful improvement following a course of TPE, particularly when combined with NAD+ therapy and mitochondrial support.
Autoimmune and Neurological Conditions
TPE is an established first-line or adjunctive treatment for conditions including myasthenia gravis, Guillain-Barré syndrome, CIDP, autoimmune encephalitis, and other disorders driven by pathogenic antibodies. Patients with complex autoimmune presentations who have not responded to conventional immunotherapy may find meaningful benefit.
Chronic Inflammation and Biological Aging
Chronic low-grade inflammation—sometimes called inflammaging—is increasingly recognized as a driver of biological aging. By reducing circulating inflammatory cytokines, autoantibodies, and oxidized lipids, TPE may support healthier aging and improved cellular function. The Circulate Trial, which combined plasma exchange with NAD+ support, demonstrated measurable improvements in biological age markers, strength, and balance.
Environmental Toxin Load
Plasma exchange can physically remove fat-soluble toxins, heavy metals bound to transport proteins, mold mycotoxins, and other environmental contaminants that accumulate in the blood and contribute to chronic disease.
What to Expect During Treatment
Each TPE session at AgeReversalMD is conducted in a private, medically supervised setting. A typical session lasts between two and four hours, depending on the protocol and patient tolerance.
Before your session, you will be advised to stay well-hydrated and eat a light meal. Blood access is established through peripheral veins. During the procedure, blood is drawn, passed through the apheresis system where plasma is separated and removed, and the cleaned blood components are returned to the body with albumin replacement fluid. The process is continuous and closed-circuit.
During the infusion, you may experience sensations such as mild tingling around the mouth or fingers, which relates to calcium shifts and resolves with supplementation. After treatment, most patients report feeling lighter, clearer-headed, and more energetic. Some may experience mild fatigue or temporary detoxification symptoms, especially during the first few sessions. Rest and hydration are encouraged post-treatment.
Personalized Protocols
Dr. Phillip Milgram develops individualized TPE protocols based on your health history, laboratory findings, and treatment goals. A typical course may include:
- Comprehensive pre-treatment laboratory workup, including autoantibody panels, inflammatory markers, and spike protein testing where indicated
- An initial series of plasma exchange sessions over a two to four week period
- Post-treatment laboratory testing to measure reduction in pathogenic markers
- Integration with IV NAD+ therapy, peptide protocols, and IV vitamins for cellular regeneration
- Maintenance sessions scheduled based on clinical response and laboratory trends
Patients with severe post-vaccine syndrome or Long COVID may require more intensive initial protocols, while those seeking longevity optimization may benefit from periodic maintenance sessions.
Safety and Side Effects
Therapeutic Plasma Exchange has an excellent safety profile when administered by trained professionals. Published clinical trials have consistently shown that TPE is well-tolerated, with favorable safety even in patients with significant underlying illness. Side effects are generally mild and may include:
- Temporary tingling around the mouth or fingers, related to calcium shifts
- Mild fatigue during or after the session
- Temporary bruising at the venous access site
- Rare allergic reactions to replacement fluids
Dr. Milgram and his team monitor every session closely, provide calcium and magnesium support when indicated, and adjust protocols to ensure patient comfort and safety.
Why Choose Dr. Phillip Milgram and AgeReversalMD?
Dr. Phillip Milgram brings over four decades of clinical experience to every patient encounter. As a former Clinical Instructor and Assistant Clinical Professor at the UCSD School of Medicine, he combines academic rigor with compassionate, personalized care. His expertise in advanced intervention, detoxification, and preventive medicine makes him uniquely qualified to guide vaccine-injured and Long COVID patients through plasma exchange and integrated recovery protocols.
At AgeReversalMD, patients receive:
- Therapeutic Plasma Exchange administered on-site in La Jolla, California
- Evidence-based protocols tailored to individual health status and goals
- Comprehensive pre- and post-treatment laboratory analysis
- Integration with NAD+, peptide, and hormone therapies for synergistic recovery
- A serene, private clinical environment on the California coast
- Integrated care that addresses root causes, not just symptoms
Scientific Support
Therapeutic Plasma Exchange is supported by decades of peer-reviewed research. It is a recognized treatment in the American Society for Apheresis (ASFA) guidelines for multiple autoimmune and neurological conditions. Published research has demonstrated that plasma exchange can:
- Reduce circulating autoantibodies and immune complexes
- Lower inflammatory cytokine levels
- Decrease fibrinogen and improve blood rheology
- Support recovery in autoimmune neurological conditions
- Remove oxidized lipids and lipoprotein abnormalities
- Provide symptomatic improvement in Long COVID and post-viral syndromes when combined with regenerative support
Ongoing clinical efforts by Dr. Mary Talley Bowden, Kevin McCairn, PhD, and the international vaccine-injury research community continue to advance the understanding of how plasma-based therapies can best serve vaccine-injured and Long COVID patients. Dr. Milgram’s integrated protocol brings that science to patients in the United States.
Schedule a Consultation
If you are ready to explore the benefits of Therapeutic Plasma Exchange, Dr. Phillip Milgram and the team at AgeReversalMD are here to help. Whether you are recovering from a post-vaccine syndrome, navigating Long COVID, managing a chronic autoimmune condition, or seeking to reduce the inflammatory burden that drives biological aging, plasma exchange may be the key to unlocking your next level of health.
You do not need to travel to Tokyo to access plasma-based therapy. Contact AgeReversalMD in La Jolla to schedule a consultation and learn whether TPE is right for you.
Pricing available upon consultation.